Skip to content

Compare medicines

Put up to three medicines side by side. Useful for alternatives in the same class, or for seeing how two very different treatments differ.

Attribute
In shortNew-generation drug for multidrug-resistant tuberculosis.Cornerstone TB drug that turns body fluids orange.
Body systemAntibioticsAntibiotics
Drug classAnti-tuberculosis drugsAnti-tuberculosis drugs
SupplyPrescription onlyWHO essential medicinePrescription onlyWHO essential medicine
Main usesMultidrug-resistant TB, Pre-extensively drug-resistant TBTuberculosis, Leprosy, Meningitis prevention in contacts, Prosthetic joint infections (with other drugs)
How it worksBlocks the energy-making machinery of TB bacteria.Stops TB bacteria making RNA.
Starts workingWeeks—
Half-lifeAbout 5.5 months (terminal)2–5 hours
Typical adult dose400 mg once a day for 2 weeks, then 200 mg three times a week (6-month regimens are also used).10 mg/kg (usually 600 mg) once a day on an empty stomach, as part of combination therapy.
FormsTabletCapsule, Oral suspension, Fixed-dose TB combination tablets, IV infusion
Common side effectsNausea, Joint pain, Headache, Raised liver enzymesOrange-red urine, sweat and tears, Nausea, Flu-like symptoms with intermittent dosing
Serious side effectsQT prolongation, Liver injury, Higher mortality signal in older trialsLiver injury, Low platelets, Kidney injury
Don't take ifQT prolongation; Severe liver disease; Use of rifampicin—
AlcoholBest avoided. Avoid alcohol; liver injury risk.—
PregnancyUse with cautionLimited data; used when needed for resistant TB.Generally considered safeTB treatment including rifampicin is recommended in pregnancy; vitamin K is given to the newborn.
BreastfeedingUse with cautionLimited data; weigh against infant exposure.—
In use since—1968
Brand namesUnited States: SirturoUnited Kingdom: SirturoIndia: SirturoUnited States: RifadinUnited Kingdom: Rifadin, RimactaneIndia: R-Cin, Rcinex (with isoniazid)
Legal statusUnited States: Prescription onlyUnited Kingdom: Prescription-only medicine (POM)India: Schedule H—
ATC codeJ04AK05J04AB02

Taken together

  • ModerateBedaquiline + Rifampicin: Reduced effect

    Enzyme induction lowers levels of this medicine, which may stop it working.

Open in the interaction checker